WST Earnings West Pharmaceutical Services
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–60 of 60
| Q3 2026 | 2026-09-30 | 3.02 | 2026-10-29 | 10-Q |
| Q2 2026 | 2026-06-30 | 2.15 | 2026-07-23 | 10-Q |
| Q1 2026 | 2026-03-31 | 1.92 | 2026-04-23 | 10-Q |
| Q4 2025 (derived) | 2025-12-31 | 1.82 | 2026-02-17 | 10-K |
| FY 2025 | 2025-12-31 | 6.79 | 2026-02-17 | 10-K |
| Q3 2025 | 2025-09-30 | 1.92 | 2025-10-23 | 10-Q |
| Q2 2025 | 2025-06-30 | 1.82 | 2025-07-24 | 10-Q |
| Q1 2025 | 2025-03-31 | 1.23 | 2025-04-24 | 10-Q |
| Q4 2024 (derived) | 2024-12-31 | 1.78 | 2025-02-18 | 10-K |
| FY 2024 | 2024-12-31 | 6.69 | 2025-02-18 | 10-K |
| Q3 2024 | 2024-09-30 | 1.85 | 2024-10-24 | 10-Q |
| Q2 2024 | 2024-06-30 | 1.51 | 2024-07-25 | 10-Q |
| Q1 2024 | 2024-03-31 | 1.55 | 2024-04-25 | 10-Q |
| Q4 2023 (derived) | 2023-12-31 | 1.83 | 2024-02-20 | 10-K |
| FY 2023 | 2023-12-31 | 7.88 | 2024-02-20 | 10-K |
| Q3 2023 | 2023-09-30 | 2.14 | 2023-10-26 | 10-Q |
| Q2 2023 | 2023-06-30 | 2.06 | 2023-07-27 | 10-Q |
| Q1 2023 | 2023-03-31 | 1.85 | 2023-04-27 | 10-Q |
| Q4 2022 (derived) | 2022-12-31 | 1.37 | 2023-02-21 | 10-K |
| FY 2022 | 2022-12-31 | 7.73 | 2023-02-21 | 10-K |
| Q3 2022 | 2022-09-30 | 1.59 | 2022-10-27 | 10-Q |
| Q2 2022 | 2022-06-30 | 2.48 | 2022-07-28 | 10-Q |
| Q1 2022 | 2022-03-31 | 2.29 | 2022-04-28 | 10-Q |
| Q4 2021 (derived) | 2021-12-31 | 1.90 | 2022-02-22 | 10-K |
| FY 2021 | 2021-12-31 | 8.67 | 2022-02-22 | 10-K |
| Q3 2021 | 2021-09-30 | 2.31 | 2021-10-28 | 10-Q |
| Q2 2021 | 2021-06-30 | 2.47 | 2021-07-30 | 10-Q |
| Q1 2021 | 2021-03-31 | 1.99 | 2021-04-30 | 10-Q |
| Q4 2020 | 2020-12-31 | 1.29 | 2021-02-23 | 10-K |
| FY 2020 | 2020-12-31 | 4.57 | 2021-02-23 | 10-K |
| Q3 2020 | 2020-09-30 | 1.09 | 2020-10-23 | 10-Q |
| Q2 2020 | 2020-06-30 | 1.21 | 2020-07-24 | 10-Q |
| Q1 2020 | 2020-03-31 | 0.99 | 2020-04-24 | 10-Q |
| Q4 2019 | 2019-12-31 | 0.84 | — | — |
| FY 2019 | 2019-12-31 | 3.21 | 2020-02-24 | 10-K |
| Q3 2019 | 2019-09-30 | 0.75 | 2019-10-29 | 10-Q |
| Q2 2019 | 2019-06-30 | 0.88 | 2019-07-29 | 10-Q |
| Q1 2019 | 2019-03-31 | 0.73 | 2019-05-08 | 10-Q |
| Q4 2018 (derived) | 2018-12-31 | 0.68 | 2019-02-28 | 10-K |
| FY 2018 | 2018-12-31 | 2.74 | 2019-02-28 | 10-K |
| Q3 2018 | 2018-09-30 | 0.73 | 2018-10-30 | 10-Q |
| Q2 2018 | 2018-06-30 | 0.75 | 2018-07-31 | 10-Q |
| Q1 2018 | 2018-03-31 | 0.58 | 2018-05-08 | 10-Q |
| Q4 2017 (derived) | 2017-12-31 | 0.00 | 2018-02-26 | 10-K |
| FY 2017 | 2017-12-31 | 1.99 | 2018-02-26 | 10-K |
| Q3 2017 | 2017-09-30 | 0.67 | 2017-10-31 | 10-Q |
| Q2 2017 | 2017-06-30 | 0.51 | 2017-08-01 | 10-Q |
| Q1 2017 | 2017-03-31 | 0.81 | 2017-05-05 | 10-Q |
| Q4 2016 (derived) | 2016-12-31 | 0.51 | 2017-02-28 | 10-K |
| FY 2016 | 2016-12-31 | 1.91 | 2017-02-28 | 10-K |
| Q3 2016 | 2016-09-30 | 0.50 | 2016-10-31 | 10-Q |
| Q2 2016 | 2016-06-30 | 0.60 | 2016-08-01 | 10-Q |
| Q1 2016 | 2016-03-31 | 0.30 | 2016-05-06 | 10-Q |
| Q4 2015 (derived) | 2015-12-31 | 0.45 | 2016-02-26 | 10-K |
| FY 2015 | 2015-12-31 | 1.30 | 2016-02-26 | 10-K |
| Q3 2015 | 2015-09-30 | 0.02 | 2015-11-02 | 10-Q |
| Q2 2015 | 2015-06-30 | 0.38 | 2015-08-03 | 10-Q |
| Q1 2015 | 2015-03-31 | 0.45 | 2015-05-06 | 10-Q |
| Q4 2014 (derived) | 2014-12-31 | 0.42 | 2015-02-25 | 10-K |
| FY 2014 | 2014-12-31 | 1.75 | 2015-02-25 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.